Xolair 150 MG/ML syringeml
Ended Awarded
- Contract number
- SPE2DB25FX7Z5
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $6,190
Award facts
- Contract value 100% obligated
- $6,189.60 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $6,189.60 to DMS Pharmaceutical Group Inc. on September 24, 2025, for the supply of Xolair 150 mg/ml syringes. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will fulfill this order with an ultimate completion date of October 16, 2025. The contract is structured as a firm fixed-price delivery order with no set-aside designation, allowing the vendor to compete on a competitive basis despite its small business status.
This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency valued at $499,999,999 and valid through November 2026. The parent IDC enables DLA to procure a comprehensive range of pharmaceutical products, including branded and generic prescription drugs, biologics, and medical consumables to support medical supply needs across Department of Defense healthcare facilities worldwide. Xolair, a biologic medication used primarily for severe allergic asthma and chronic urticaria treatment, represents one of the specialized pharmaceutical products within the broader contract portfolio supporting military health operations.
Quick answers
Who was awarded contract SPE2DB25FX7Z5?
SPE2DB25FX7Z5 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 24, 2025.
How much is contract SPE2DB25FX7Z5 worth?
The government has obligated $6,190 on SPE2DB25FX7Z5.
Is contract SPE2DB25FX7Z5 an order under another contract?
Yes. SPE2DB25FX7Z5 is a delivery order under SPE2DB20D9354, an indefinite delivery contract.
Was contract SPE2DB25FX7Z5 competed?
The extent of competition for SPE2DB25FX7Z5 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award